144 related articles for article (PubMed ID: 37394916)
21. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions.
Lovly CM; Gupta A; Lipson D; Otto G; Brennan T; Chung CT; Borinstein SC; Ross JS; Stephens PJ; Miller VA; Coffin CM
Cancer Discov; 2014 Aug; 4(8):889-95. PubMed ID: 24875859
[TBL] [Abstract][Full Text] [Related]
22. Locally Advanced Inflammatory Myofibroblastic Tumor Treated With Targeted Therapy: A Case Report and Literature Review.
Durham C; Clemons M; Alias A; Konduri K
Cureus; 2022 Jul; 14(7):e27223. PubMed ID: 36035049
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges.
Mahajan P; Casanova M; Ferrari A; Fordham A; Trahair T; Venkatramani R
Curr Probl Cancer; 2021 Aug; 45(4):100768. PubMed ID: 34244015
[TBL] [Abstract][Full Text] [Related]
24. Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours.
Preobrazhenskaya EV; Suleymanova AM; Bizin IV; Zagrebin FA; Romanko AA; Saitova ES; Mulkidzhan RS; Imyanitov EN
Histopathology; 2023 Jul; 83(1):109-115. PubMed ID: 37071060
[TBL] [Abstract][Full Text] [Related]
25. Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion.
Bennett JA; Wang P; Wanjari P; Diaz L; Oliva E
Genes Chromosomes Cancer; 2021 Dec; 60(12):822-826. PubMed ID: 34322931
[TBL] [Abstract][Full Text] [Related]
26. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
[TBL] [Abstract][Full Text] [Related]
27. Case report: Crizotinib is effective in a patient with ROS1-rearranged pulmonary inflammatory myofibroblastic tumor.
Mai S; Xiong G; Diao D; Wang W; Zhou Y; Cai R
Lung Cancer; 2019 Feb; 128():101-104. PubMed ID: 30642440
[TBL] [Abstract][Full Text] [Related]
28. Novel treatment of endobronchial inflammatory myofibroblastic tumor in a child.
Reyes-Angel J; Rapkin LB; Simons JP; Muzumdar H
Pediatr Pulmonol; 2022 Jan; 57(1):330-332. PubMed ID: 34710285
[TBL] [Abstract][Full Text] [Related]
29. Histopathologic and Molecular Characterization of Uterine Leiomyoma-like Inflammatory Myofibroblastic Tumor: Comparison to Molecular Subtypes of Uterine Leiomyoma.
Kuisma H; Jokinen V; Pasanen A; Heikinheimo O; Karhu A; Välimäki N; Aaltonen L; Bützow R
Am J Surg Pathol; 2022 Aug; 46(8):1126-1136. PubMed ID: 35426837
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H
Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
[TBL] [Abstract][Full Text] [Related]
31. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
Parker BM; Parker JV; Lymperopoulos A; Konda V
J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
[TBL] [Abstract][Full Text] [Related]
32. Partial Response to Ceritinib in a Patient With Abdominal Inflammatory Myofibroblastic Tumor Carrying a TFG-ROS1 Fusion.
Li Y; Chen X; Qu Y; Fan JM; Li Y; Peng H; Zheng Y; Zhang Y; Zhang HB
J Natl Compr Canc Netw; 2019 Dec; 17(12):1459-1462. PubMed ID: 31805529
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.
Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P
Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
[TBL] [Abstract][Full Text] [Related]
35. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor.
Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H
Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory myofibroblastic tumor of bone harboring an ALK gene amplification.
Wang K; Guo R; Siegal GP; Wei S
Pathol Res Pract; 2019 Sep; 215(9):152535. PubMed ID: 31326196
[TBL] [Abstract][Full Text] [Related]
37. DCTN1-ALK gene fusion in inflammatory myofibroblastic tumor (IMT) of the CNS.
Vidrine DW; Berry JF; Garbuzov A; Falcon C; Tubbs RS; Bui CJ
Childs Nerv Syst; 2021 Jul; 37(7):2147-2151. PubMed ID: 34014367
[TBL] [Abstract][Full Text] [Related]
38. Durable response to serial tyrosine kinase inhibitors (TKIs) in an adolescent with metastatic TFG-ROS1 fusion positive Inflammatory Myofibroblastic Tumor (IMT).
Ingley KM; Hughes D; Hubank M; Lindsay D; Plumb A; Cox R; Chesler L; Strauss SJ
Lung Cancer; 2021 Aug; 158():151-155. PubMed ID: 34059352
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary inflammatory myofibroblastic tumor harboring EML4-ALK fusion gene.
Sokai A; Enaka M; Sokai R; Mori S; Mori S; Gunji M; Fujino M; Ito M
Jpn J Clin Oncol; 2014 Jan; 44(1):93-6. PubMed ID: 24277751
[TBL] [Abstract][Full Text] [Related]
40. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.
Lawrence B; Perez-Atayde A; Hibbard MK; Rubin BP; Dal Cin P; Pinkus JL; Pinkus GS; Xiao S; Yi ES; Fletcher CD; Fletcher JA
Am J Pathol; 2000 Aug; 157(2):377-84. PubMed ID: 10934142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]